Keeping Oral o Parental AnticoaguLation in the Acute Phase of Cardioembolic Ischemic Stroke — KOALA-IS  

Anticoagulant Therapy Clinical Trial

Official title: Keeping Oral o Parental AnticoaguLation in the Acute Phase of Cardioembolic Ischemic

Status Recruiting

Clinical Trial Summary

This is an observational, prospective, multicenter, cohort study in patients with cardioembolic stroke and previous oral or parenteral anticoagulant therapy. Patients in which anticoagulante therapy is mantained will be compared to those in which it is interrupted, in terms of stroke or systemic embolism and haemorrhagic transformation.

Clinical Trial Description

Observational, prospective, multicenter, cohort study in patients with recent cardioembolic stroke (<24 hours) and previous oral or parenteral anticoagulant therapy (last dose recieved <24hours) . Patients in which anticoagulante therapy is mantained will be compared to those in which it is interrupted. The decision to mantain or interrumpt the anticoagulant therapy is made by the treating physician as hospital protocol. Stroke recurrence, haemorrhagic transformation at 90 days are evalauted and also complication during the hospitalization and functional outcome. ;

Related Conditions & MeSH terms

• Anticoagulant Therapy
• Cardioembolic Stroke
• Embolic Stroke
• Recurrence
• Stroke
• Stroke Recurrence

• NCT number: NCT05486351
• Study type: Observational
• Source: Instituto de Investigación Hospital Universitario La Paz
• Contact: Ricardo Rigual Bobillo, MD
• Phone: 917277444
• Email: [email protected]
• Status: Recruiting
• Start date: March 5, 2021
• Completion date: December 31, 2023